[1]
T. Tojo and M. Yamaoka-Tojo, “Lifestyle Modification-Improving Systemic Athero-Protective Factor, Circulating Pentraxin 3, in High-Risk Patients with Metabolic Syndrome”, ccm, vol. 5, no. 2, pp. 201–212, Mar. 2021.